Prokarium

London, United Kingdom · Founded 2012 · Privately Held (backing)

Operator of a biopharmaceutical company intended for developing bacterial immunotherapies for cancer. Prokarium is based in London, United Kingdom and was founded in 2012. Its last reported valuation was $109 million in Feb 2023. It has raised $88.8 million.

Last reported valuation

$109.4M

Oct 2026

Priced at

—

Total raised

$88.8M

Last round

—

How much has Prokarium raised?

$88.8Macross 0 recorded rounds

Free account

More of Prokarium with a free account

·The complete investor list: 12 names
·Watch Prokarium: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Prokarium investors

12 investors are on record for Prokarium, including Innovate UK, Korea Investment Partners, London & Partners. and British Business Bank.

For fundraisers

Raising for a company like Prokarium?

12 investors have backed Prokarium.

See all 12 investors →

Frequently asked about Prokarium

How much has Prokarium raised?: Prokarium has raised $88.8M in total across 0 recorded funding rounds.